NON-EXCLUSIVE PATENT LICENSE Sample Clauses

NON-EXCLUSIVE PATENT LICENSE. LICENSOR agrees and does hereby grant LICENSEE the non-exclusive right and license to manufacture, use, sell and otherwise practice the Licensed Invention in the United States of America its territories and possessions and all foreign countries, subject to any limitations below (all of which is collectively termed the Licensed Territory), such right and license being only. for LICENSEE and not sub-licensable, except as may otherwise be explicitly permitted herein, until the expiration of the last to expire of any and all Patent(s) or any reissue(s) or extension(s) thereof, which may issue on the Licensed Invention (the Licensed Patent Rights), unless sooner terminated in; accordance with any of the provisions hereof. LICENSEE agrees that a will manufacture embodiments of the Licensed invention. However, should LICENSEE or a related company use the Licensed Invention for profit, or otherwise practice the Licensed Invention, the embodiments of the Licensed Invention so used shall be considered as sold to LICENSEE at the highest sales price charged to a third party for an embodiment of the Licensed Invention for the purpose of calculating royalties.
AutoNDA by SimpleDocs
NON-EXCLUSIVE PATENT LICENSE. Subject to the terms and conditions set forth herein, immediately upon, and contemporaneously with, the Closing Date, and without further action by the Parties, Mount Sinai hereby grants to Licensee a non-sublicensable, non-transferable, royalty-bearing, non-exclusive license to the Licensed Patents identified in Exhibit B, solely to Exploit Licensed Products in the Field of Use, during the Term, throughout the Territory. For clarity and avoidance of doubt, this license grant does not permit Licensee to disclose or transfer any rights in the Licensed Patents to any Third Party.
NON-EXCLUSIVE PATENT LICENSE. Ares Trading S.A., an Affiliate of EMD Serono, hereby grants to Thera a fully paid up, royalty free and non-exclusive license, effective as of the Closing Date, under U.S patent number 7,144,577 (Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy) (“US Patent 7,144,577”) to make, use, offer to sell, sell and import the Product throughout the Territory.
NON-EXCLUSIVE PATENT LICENSE. Subject to the terms and conditions of this Agreement, starting on the Effective Date and continuing for the duration of the Term (as defined in Section 3.1), for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Licensor hereby grants to Licensee a fully paid-up, royalty-free, worldwide, non-transferable, non-exclusive license under the Licensed Patents to make (including the right to practice methods, processes, and procedures), have made (subject to Section 2.2), use, sell, offer for sale, and import Licensed Products. Except as set forth in Section 2.10, the license granted under this Section 2.1 does not include the right to grant sublicenses and Licensee is specifically prohibited from granting sublicenses without Licensor’s specific, prior, written consent, provided however, the parties hereby agree that the license granted under this Section 2.1 shall extend to customers, distributors, resellers and other persons involved in the distribution, manufacture, sale, offer for sale, import or use of Licensed Products, but only to the extent such manufacture, use, sale offer for sale and/or import activities are limited to Licensed Products.
NON-EXCLUSIVE PATENT LICENSE. In connection with this Agreement, ArQule has granted to PRI a non-exclusive license to practice certain of its United States patents. The terms and conditions of this patent license are set forth on EXHIBIT A.
NON-EXCLUSIVE PATENT LICENSE. Novartis hereby grants to Vanda under the patent covering a biomarker as identified hereto in ANNEX 1 a license under the same terms as with respect to the Novartis Patents under the Agreement however such license shall be: a) non-exclusive and b) limited as far as such patent identified in ANNEX 1 covers any aspects of Iloperidone; Contrary to Section 8.3 of the Agreement relating to the other Novartis Patents, Novartis will retain all financial, filing, maintenance and prosecution (including oppositions) responsibility for the patent identified in ANNEX 1 hereto.

Related to NON-EXCLUSIVE PATENT LICENSE

  • Patent License Licensor hereby grants to Licensee an exclusive, royalty-bearing, non-transferable license under the Licensed Patents to make, offer to sell, sell and export Licensed Products within the Field of Use and subject to the Field of Use Restrictions. This license shall not include the right to grant sublicenses.

  • PATENT LICENSE AGREEMENT EXCLUSIVE PHS and Licensee agree as follows:

  • Non-Exclusive License NCPS grants Company a revocable, non-exclusive, non-transferable and non-sublicensable license during the Term to view-only access the PPEX ATS through the PPEX Site and its related software and other applications and technology for the sole purpose of viewing information about Company and Company Securities and Trades of Company Securities. This license is in addition to the license Company has and is required to maintain during the Term (as defined below) with NCPS’s affiliate, North Capital Investment Technology, Inc., for TransactAPI pursuant to a separate Software and Services License Agreement (“SSLA”). The technology covered by the licenses outlined in this Section 2 is collectively referred to herein as the “Technology”.

  • Patent Licenses (a) Upon payment of the applicable fees as set forth in Appendix B3 and subject to the provisions of this Agreement, Lucent hereby grants to Company during the License Term, a personal, non-transferable (except as permitted in Section 5.08) and non-exclusive license (without any right to sublicense) under (a) patents and/or patent applications listed in Appendix C, (b) patents on sole inventions (as defined in Section 2.03(a) owned by Lucent, to (i) perform the Development Project during the Development Period, and (ii) to make, have made, use, lease, sell, offer to sell and import Licensed Product.

  • Trademark License (a) Reuters and TSI acknowledge that Reuters has, pursuant to the Existing License Agreement, assigned to TSI all of its (and TFT’s) right, title and interest in and to the Transferred TIB-Related Marks and all goodwill associated therewith. Reuters hereby continues to assign to TSI any right, title and interest that it may have or obtain in the Transferred TIB-Related Marks or the goodwill associated therewith. At TSI’s sole expense, Reuters shall perform such acts and execute such documents as are reasonably required to perfect the foregoing assignment and obtain and enforce trademark, service xxxx and other similar rights in the Transferred TIB-Related Marks. TSI hereby grants to Reuters a perpetual, royalty-free, irrevocable, worldwide right and license in favor of Reuters and its Affiliates to use Transferred TIB-Related Marks in connection with the marketing, use, sale and distribution of any of Reuters’ and their Affiliates’ respective products or the provision by Reuters or their Affiliates of any services. Reuters and its Affiliates’ right to use such Transferred TIB-Related Marks shall be only in conformance with TSI’s trademark usage guidelines delivered to Reuters from time to time, which guidelines shall be reasonable and shall not be inconsistent with the scope of the license herein granted and shall not become effective prior to thirty (30) days after notice thereof has been given by TSI. TSI shall maintain the right to substitute any alternative trademark to the Transferred TIB-Related Marks in the event such Transferred TIB-Related Xxxx is held to infringe any other xxxx; provided that, if TSI advises either or both of Reuters in writing of an alleged infringement, Reuters will be responsible for any and all losses, liabilities, damages, costs and expenses assessed or incurred as a result of such actual or alleged infringement that accrue on or after the date of such notice.

  • Non-Exclusive License Grant Subject to the terms and conditions of this Agreement, Takeda hereby grants to Licensee a non-exclusive, sublicensable (subject to Section 3.3 (Sublicensing)) right and license under the Takeda Technology and Takeda’s interest in the Joint Technology to: (a) Develop the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Men’s Health Field in the Takeda Territory solely for the purpose of Exploiting such Licensed Products in the Field in the Licensee Territory, or as required in order for Licensee to comply with its diligence obligations set forth in Section 5.2 (Development Diligence Obligations) and (b) Manufacture the TAK-385 Licensed Compound and TAK-385 Licensed Products in the Takeda Territory.

  • Trademark License Agreement Buyer shall have executed and delivered to Sellers the Trademark License Agreement.

  • Development License A non-transferable (except as provided in Section 17.1 (Assignment)), sublicensable (subject to Section 11.2.5 (Voyager Sublicense Rights)), worldwide, non-exclusive, royalty-free license under the Genzyme Technology, Genzyme Collaboration Technology and Genzyme’s interest in the Joint Collaboration Technology to (a) Develop the Split Territory Licensed Products and conduct such Split Territory Licensed Program inside and outside the Voyager Territory for Commercialization of such Split Territory Agreement Products in the Field in the Voyager Territory, and (b) Manufacture the Split Territory Licensed Products inside or outside of the Voyager Territory for the purposes of such Development, in each case (a) and (b) as and to the extent set forth in any Global Development Plan or Voyager Territory Development Plan.

  • Trademark Infringement (a) If either Party learns that a third party is infringing the ACTIMMUNE xxxx, it shall promptly notify the other in writing. The Parties shall use reasonable efforts in cooperation with each other to stop such trademark infringement without litigation.

  • Exclusive License Licensor hereby grants to Licensee and Licensee hereby accepts from Licensor, upon the terms and conditions herein specified, a sole and exclusive license under the Licensed Patent Rights in the Territory, and in the Field of Use to develop, make, have made, import, have imported, use, offer to sell, sell and otherwise commercialize Licensed Product(s).

Time is Money Join Law Insider Premium to draft better contracts faster.